Clinical Trials for EMD Serono

M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors

A Study to Assess the Bioequivalence of Follitropin Alfa Solution in Pen and Follitropin Alfa Powder in Vial in Healthy Downregulated Male Participants

Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)

Avelumab and M1774 in ARID1A-mutated Endometrial Cancer

Anti-GD2 ADC M3554 in Advanced Solid Tumors

Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501)

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments

FSH and LH Versus FSH Alone for Ovarian Stimulation in Non-hormone Sensitive Onco-fertility Patients

Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer

Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)

Met Non Small Cell Cancer Registry (MOMENT)

A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)

Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)

Study of Tuvusertib (M1774) in Combination With DNA Damage Response Inhibitor or Immune Checkpoint Inhibitor (DDRiver Solid Tumors 320)

Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS Tumors

Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma

A Prospective Biomarker Study in Active SPMS Subjects Treated With Cladribine Tablets

Cladribine Tablets After Treatment With Natalizumab (CLADRINA)

Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma

Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)

A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)

Avelumab Program Rollover Study

Adjuvant Avelumab in Merkel Cell Cancer

Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)